Abstract
We have developed a simple and highly efficient method to detect deletions and insertions in the p53 gene. All 11 exons of the p53 gene were amplified along with a control sequence in four multiplex PCR reactions in the presence of fluorescein‐labeled primers. The PCR products were resolved on an automated sequencing gel and the DNA fragments were detected by fluorescence. Using this method, we screened 7 DNA specimens from ovarian tumors, 19 from breast tumors, and 26 from normal breast tissues. No abnormality was found in any of the DNA samples extracted from the normal tissues. A 19 base pair deletion in exon 5 of the p53 gene was detected in one ovarian tumor. Insertions were identified in two breast and two ovarian tumors. The insertions were identical in 3 of these tumors and consisted of a 16 bp repeat within intron 3 of the p53 gene. It appears that the insertion within intron 3 may represent a hot spot for duplication of the normal sequence at that site. J. Clin. Lab. Anal. 12:250–256, 1998. © 1998 Wiley‐Liss, Inc.
Keywords: p53 gene, gene deletions, gene insertions, fragment analysis, DNA sequencing, ovarian cancer, breast cancer
References
- 1. Lane, DP : p53, guardian of the genome. Nature 358: 15–16, 1992. [DOI] [PubMed] [Google Scholar]
- 2. Vogelstein B, Kinzler KW: p53 function and dysfunction. Cell 70: 523–526, 1992. [DOI] [PubMed] [Google Scholar]
- 3. Marx, J : How p53 suppresses cell growth. Science 262: 1644–1645, 1993. [DOI] [PubMed] [Google Scholar]
- 4. El‐Deiry WS, Tokino T, Velculescu VE, et al.: WAF1, a potential mediator of p53 tumor suppression. Cell 7: 817–825, 1993. [DOI] [PubMed] [Google Scholar]
- 5. Kastan MB, Zhan Q, El‐Deiry WS, et al.: A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia‐telangiectasia. Cell 71: 587–597, 1992. [DOI] [PubMed] [Google Scholar]
- 6. Barak Y, Juven T, Haffner R, Oren M: Mdm‐2 expression is induced by wild‐type p53 activity. EMBO J 12: 461–468, 1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Wales M, Biel MA, El‐Deiry W, et al.: p53 activates expression of HIC‐1, a new candidate tumor suppressor gene on 17pl3.3. Nature Med 1: 570–577, 1995. [DOI] [PubMed] [Google Scholar]
- 8. Buckbinder L, Talbott R, Velasco‐Miguel S, et al.: Induction of the growth inhibitor IGF‐binding protein 3 by p53. Nature 377: 646–649, 1995. [DOI] [PubMed] [Google Scholar]
- 9. Seto E, Usheva A, Zambetti GP, et al.: Wild‐tpe p53 binds to the TATA‐binding protein and represses transcription. Proc Natl Acad Sci USA 89: 12028–12032, 1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Miyashita T, Harigai M, Hanada M, Reed JC: Identification of a p53‐dependent negative response element in the bcl‐2 gene. Cancer Res 54: 3131–3135, 1994. [PubMed] [Google Scholar]
- 11. Bakalkin G, Yakovleva T, Selivanova G, et al.: p53 binds single‐stranded DNA ends and catalyzes DNA renaturation and strand transfer. Proc Natl Acad Sci USA 91: 413–417, 1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Levine AJ, Momand J, Finlay, CA : The p53 tumor suppressor gene. Nature 351: 453–456, 1991. [DOI] [PubMed] [Google Scholar]
- 13. Hollstein M, Sidransky D, Vogelstein B, Harris CC: p53 mutations in human cancers. Science 253: 49–53, 1991. [DOI] [PubMed] [Google Scholar]
- 14. Baker SJ, Preisinger AC, Jessup JM, et al.: p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res 50: 7717–7722, 1990. [PubMed] [Google Scholar]
- 15. Prosser J, Thompson AL, Cranston G, Evans HJ: Evidence that p53 behaves as a tumor suppressor gene in sporadic breast tumors. Oncogene 5: 1573–1579, 1990. [PubMed] [Google Scholar]
- 16. Takahashi T, Nau MM, Chiba I, et al.: p53‐a frequent target for genetic abnormalities in lung cancer. Science 246: 491–494, 1989. [DOI] [PubMed] [Google Scholar]
- 17. Mazars R, Pujol P, Maudelonde T, Jeanteur P, Theillet C: p53 mutations in ovarian cancer‐a late event. Oncogene 6: 1685–1690, 1991. [PubMed] [Google Scholar]
- 18. Mashiyama S, Murakami Y, Yoshimoto T, Sekiya T, Hayashi K: Detection of p53 gene mutations in human brain tumors by single‐strand conformation polymorphism analysis of polymerase chain reaction products. Oncogene 6: 1313–1318, 1991. [PubMed] [Google Scholar]
- 19. Gaidano G, Ballerini P, Gong JZ, et al. p53 mutations in human lymphoid malignancies‐association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc Natl Acad Sci USA 1991; 88: 5413–5417. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Miller CW, Aslo A, Tsay C, et al.: Frequency and structure of p53 rearrangements in human osteosarcoma. Cancer Res 50: 7950–7954, 1990. [PubMed] [Google Scholar]
- 21. Jego N, Thomas G, Hamelin R: Short direct repeats flanking deletions and duplicating insertions in p53 gene in human cancers. Oncogene 8: 209–213, 1993. [PubMed] [Google Scholar]
- 22. Runnebaum IB, Tong XW, Moebus V, Heilmann V, Keiback DG, Kreienberg R: Multiplex PCR screening detects small p53 deletions and insertions in human ovarian cancer cell lines. Hum Genet 93: 620–624, 1994. [DOI] [PubMed] [Google Scholar]
- 23. Ausubel FM, et al.: Current Protocols in Molecular Biology. Vol 1, 2.2.1–2.2.2. John Wiley & Sons, Inc., 1995. [Google Scholar]
- 24. Hartmann A, Blaszyk H, McGovern RM, et al.: p53 gene mutations inside and outside of exons 5‐8: the patterns differ in breast and other cancers. Oncogene 10: 681–688, 1995. [PubMed] [Google Scholar]
- 25. Lazar V, Hazard F, Bertin F, Janin N, Bellet D, Bressac B: Simple sequence repeat polymorphism within the p53 gene. Oncogene 8: 1703–1705, 1993. [PubMed] [Google Scholar]
- 26. Hassapoglidou S, Diamandis EP, Sutherland DJA: Quantification of p53 protein in tumor cell lines, breast tissue extracts and serum with time‐resolved immunofluorometry. Oncogene 8: 1501–1509, 1993. [PubMed] [Google Scholar]